This site uses cookies.
Learn more.

×

This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

image of severe asthma in lung section

Severe Asthma: Novel Concepts & Therapeutics

Friday, April 26, 2019, 9:00 AM - 6:00 PM

The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Presented By

The New York Academy of Sciences

The Biochemical Pharmacology Discussion Group

 

Asthma is a chronic, heterogeneous inflammatory disease of the airways, affecting approximately 300 million people worldwide. Severe asthma is defined as an uncontrolled or only partially controlled form of asthma despite intensive treatment. It affects 5-10% of the adult asthma population and is associated with increased morbidity, mortality, and consumption of health care resources. Limited knowledge of the disease mechanisms is the greatest obstacle to the development of novel treatments. This symposium will focus on novel insights into the pathophysiology of severe asthma as well as on offering perspectives on potential new therapeutic opportunities.

Photo courtesy of Dylan Birchard, Regeneron

Call for Abstracts

Abstract submissions are invited for a poster session. For complete submission instructions, please visit our online portal. The deadline for abstract submission is February 26, 2019.

Registration

Member
By 03/15/2019
$90
After 03/15/2019
$130
Nonmember Academia, Faculty, etc.
By 03/15/2019
$180
After 03/15/2019
$260
Nonmember Corporate, Other
By 03/15/2019
$250
After 03/15/2019
$350
Nonmember Not for Profit
By 03/15/2019
$180
After 03/15/2019
$260
Nonmember Student, Undergrad, Grad, Fellow
By 03/15/2019
$100
After 03/15/2019
$145
Member Student, Post-Doc, Fellow
By 03/15/2019
$50
After 03/15/2019
$70
Earlybird Registration:
148
days
left
Deadline:
131
days
left

Scientific Organizing Committee

David Artis, PhD,
Weill Cornell Medicine
Roland Kolbeck, PhD,
MedImmune
Jamie Orengo, PhD,
Regeneron Pharmaceuticals
Matthew Sleeman, PhD,
Regeneron Pharmaceuticals
Sonya Dougal, PhD,
The New York Academy of Sciences
Marie Samanovic-Golden, PhD,
The New York Academy of Sciences

Keynote Speaker

Sally Wenzel, MD,
University of Pittsburgh Asthma Institute

Speakers

David Artis, PhD,
Weill Cornell Medicine
Alison Humbles, PhD,
MedImmune
Melanie Königshoff, MD PhD,
University of Colorado
James Martin, MD,
McGill University
Kari Nadeau, MD, PhD,
Stanford University
School of Medicine
Jamie Orengo, PhD,
Regeneron Pharmaceuticals
Xin Sun, PhD,
University of California
San Diego
Additional Speakers to Be Announced

Program Support